Related Experiment Videos
Receptor polymorphisms and diseases
1Department of Medicine and Geriatrics, Faculty of Health Sciences, Semmelweis University, Szabolcs u. 33-35, H-1135, Budapest, Hungary. csaszalb@hiete.hu
Abstract:
The aim of our review is to summarize common genetic variations of some receptors associated with clinical consequences, which were not outlined in the previous special issue of this journal. Because of the multiple pathomechanisms of diseases, a set of genetic variation can play a role in the development of pathological conditions. From the data available three articles would merit a greater interest. In systemic lupus erythematosus the associations related to some polymorphisms of Fc-, tumor necrosis factor (TNF) alpha- and interferon receptor may explore new autoimmunological and inflammatorical pathomechanisms. In the endocrinology, the androgen receptor repeat polymorphism will exert significant aspects in the development of prostate cancer. The pleoitropic responsibility of vitamin D3 receptor polymorphism in the pathogenesis of immunological disorders (primary biliary cirrhosis, inflammatory bowel disease, type 1 diabetes mellitus) and of malignancies (malignant melanoma, breast cancer) shed light on the importance of common nuclear receptors. Nevertheless, in the future studies a more consistent approach minimizing requirement bias in the selection of patients will approve our understanding the role of genetic influence on the pathogenesis of diseases.
Insights
This review explores common genetic variations in receptors and their clinical impacts. Understanding these genetic links, like those in autoimmune diseases and cancer, is crucial for future research.
Area of Science:
- Genetics and Molecular Biology
- Immunology
- Endocrinology
Background:
- Genetic variations in receptors are increasingly recognized for their role in disease pathogenesis.
- Previous research has not fully detailed the clinical consequences of common receptor genetic polymorphisms.
- Multiple pathomechanisms contribute to disease development, often involving genetic factors.
Purpose of the Study:
- To summarize common genetic variations of selected receptors and their associated clinical consequences.
- To highlight the role of genetic polymorphisms in autoimmune disorders and malignancies.
- To identify areas for future research with improved methodologies.
Main Methods:
- Review of existing literature focusing on genetic variations in specific receptors.
- Analysis of associations between receptor polymorphisms and diseases such as systemic lupus erythematosus, prostate cancer, and various immunological disorders and malignancies.
- Synthesis of findings from three key articles meriting greater interest.
Main Results:
- Polymorphisms in Fc-, tumor necrosis factor (TNF) alpha-, and interferon receptors are associated with systemic lupus erythematosus, suggesting novel autoimmune and inflammatory pathways.
- Androgen receptor repeat polymorphism is significantly linked to prostate cancer development.
- Vitamin D3 receptor polymorphism plays a pleiotropic role in immunological disorders (e.g., primary biliary cirrhosis, inflammatory bowel disease, type 1 diabetes mellitus) and cancers (e.g., malignant melanoma, breast cancer).
Conclusions:
- Common genetic variations in nuclear receptors significantly influence the pathogenesis of diverse diseases, including autoimmune conditions and cancers.
- Further research with consistent approaches and minimized bias is needed to fully elucidate the role of genetic factors in disease.
- Understanding these genetic links can pave the way for targeted therapies and improved disease management.